Nephros Inc.

NEPH Healthcare Medical Instruments & Supplies

Nephros Inc.’s revenue for fiscal 2025 (year ended December 2025) was $18.8 million, up 32.7% from fiscal 2024. In the quarter to June 2026, revenue grew 36.2%, EPS grew 450.0% and free cash flow fell 31.5%, each against the same quarter a year earlier.

3.65 0.14 +3.99%
Market cap
$38.1M
P/E
23.4×
Fwd P/E
76.0×
Dividend yield
—
F-score
7/9
Altman Z
−3.26
Beneish M
−2.60
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

7 7 3 4
ROE
16.29% 12.71% 7.76% 16.10%
ROA
12.53% 9.61% 6.07% 12.39%
ROIC
18.68% 14.92% 6.33% 14.11%
Return on Tangible Assets
17.72% 13.95% 8.56% 16.80%
Average Days of Receivables
54.17 46.90 67.20 72.15
Free Cash Flow per Share
0.26 0.16 (0.03) (0.06)
Free Cash Flow
2.72 1.65 (0.35) (0.66)
Other line items

Show all line items

Columns are period end dates